Aditxt, Inc. Finance Lease, Right-of-Use Asset, after Accumulated Amortization
Aditxt, Inc. (ADTX) had Finance Lease, Right-of-Use Asset, after Accumulated Amortization of $3.97 million as of 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:FinanceLeaseRightOfUseAsset · last filed 2021-11-15
- 2021-09-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $3.97M.
- 2021-06-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $3.99M.
- 2021-03-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $1.18M.
- 2020-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $1.26M.
| Period end | Finance Lease, Right-of-Use Asset, after Accumulated Amortization |
|---|---|
| 2021-09-30 | $3.97M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $3.99M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $1.18M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $1.26M 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |